Trial · NCT00607477
Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
NCT00607477, Not applicable, Terminated, University of Chicago; results first posted 2011-02-16
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension. Trials, record NCT00607477. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00607477
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
- NCT number
- NCT00607477
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 2 participants, actual
- Lead sponsor
- University of Chicago
- Conditions
- Treatment Induced Hypertension
- Interventions
- Minoxidil, Hydralazine
- First posted
- 2008-02-05
- Last updated
- 2014-06-10
- Results first posted
- 2011-02-16
- Limitations and caveats
- This study enrolled only 2 subjects and due to poor accrual, enrollment was stopped early. Due to the limited number of subjects available results cannot be assessed.
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Magnitude of Change in Blood Pressure | 21 days |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Magnitude of Change in Blood Pressure | 21 days | No participants analyzed due to poor accrual and insufficient numbers of participants. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Hydralazine | 0 | |
| Overall Study | STARTED | Minoxidil | 2 | |
| Overall Study | COMPLETED | Hydralazine | 0 | |
| Overall Study | COMPLETED | Minoxidil | 2 | |
| Overall Study | NOT COMPLETED | Hydralazine | 0 | |
| Overall Study | NOT COMPLETED | Minoxidil | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | diarrhea (grade 1) | Gastrointestinal disorders | Hydralazine | 0 | 0 | 0 |
| other | diarrhea (grade 1) | Gastrointestinal disorders | Minoxidil | 1 | 2 | 1 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Hydralazine | ||
| Total, all-cause mortality | Minoxidil | ||
| Total, other adverse events | Hydralazine | 0 | 0 |
| Total, other adverse events | Minoxidil | 1 | 2 |
| Total, serious adverse events | Hydralazine | 0 | 0 |
| Total, serious adverse events | Minoxidil | 0 | 2 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00607477
GET https://conductscience.org/api/trials/v1/NCT00607477/registered